From intestinal metabolites to the brain: Investigating the mysteries of Long COVID

Shan Liu; Ashwarya S. Devason; Maayan Levy

doi:10.1002/ctm2.1608

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (3) : e1608 DOI: 10.1002/ctm2.1608

COMMENTARY

From intestinal metabolites to the brain: Investigating the mysteries of Long COVID

Author information +

History +

PDF

Cite this article

Download citation ▾

Shan Liu, Ashwarya S. Devason, Maayan Levy. From intestinal metabolites to the brain: Investigating the mysteries of Long COVID. Clinical and Translational Medicine, 2024, 14(3): e1608 DOI:10.1002/ctm2.1608

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	WHO Coronavirus (COVID-19) Dashboard. Accessed December 18, 2023.

[2]	Thaweethai T, Jolley SE, Karlson EW, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934-1946.

[3]	Wong AC, Devason AS, Umana IC, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186(22):4851-4867. e20

[4]	Bin NR, Prescott SL, Horio N, Wang Y, Chiu IM, Liberles SD. An airway-to-brain sensory pathway mediates influenza-induced sickness. Nature. 2023;615(7953):660-667.

[5]	VanElzakker MB. Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Med Hypotheses. 2013;81(3):414-423.

[6]	Meyerhoff J, Dorsch CA. Decreased platelet serotonin levels in systemic lupus erythematosus. Arthritis Rheum. 1981;24(12):1495-1500.

[7]	San Hernandez AM, Singh C, Valero DJ, et al. Multiple sclerosis and serotonin: potential therapeutic applications. Cureus. 2020;12(11):e11293.

[8]	Lood C, Tydén H, Gullstrand B, et al. Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus. PLoS One. 2015;10(4):e0125109.

[9]	Rus CP, de Vries BEK, de Vries IEJ, Nutma I, Kooij JJS. Treatment of 95 post-Covid patients with SSRIs. Sci Rep. 2023;13(1):18599.

[10]	Sidky H, Sahner DK, Girvin AT, Hotaling N, Michael SG, Gersing K. Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19. medRxiv. 2023. Published online February 10. 2022.11.09.22282142. medRxiv.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.